ALBERT BOURLA - 23 Feb 2022 Form 4 Insider Report for PFIZER INC (PFE)

Role: Chairman & CEO, Director
Signature: Susan E. Grant, by power of atty., for Albert Bourla
Issuer symbol: PFE
Transactions as of: 23 Feb 2022
Net transactions value: -$1,758,047
Form type: 4
Filing time: 25 Feb 2022, 16:06:54 UTC
Previous filing: 17 Feb 2022
Next filing: 01 Mar 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PFE	Common Stock	Tax liability	$1,758,047	-37,509	-15%	$46.87	209,841	23 Feb 2022	Direct	F1
holding	PFE	Common Stock						3,990	23 Feb 2022	By Rule 16b-3 Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PFE	Stock Appreciation Rights	Award	$0	+412,081		$0.000000	412,081	24 Feb 2022	Common Stock	412,081	$45.96	Direct	F2
transaction	PFE	Stock Appreciation Rights	Award	$0	+362,427		$0.000000	362,427	24 Feb 2022	Common Stock	362,427	$45.96	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the settlement of stock units from previously exercised stock appreciation rights (including dividend equivalents thereon).
F2	The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.
F3	The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.